Paclitaxel, interferons and functional reprogramming of tumor-associated macrophages in optimized chemo-immunotherapy
Immune checkpoint inhibition (ICI) targeting programmed cell death protein-1 (PD1) prevents the elimination of activated cytotoxic T lymphocytes (CTLs) by programmed death-ligand 1/2-expressing cancer and myeloid cells in the tumor microenvironment (TME). ICI has shown its effectiveness in many soli...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2025-05-01
|
| Serija: | Journal for ImmunoTherapy of Cancer |
| Online pristup: | https://jitc.bmj.com/content/13/5/e010960.full |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|